Intracameral Cefuroxime Use in Cataract Surgery After Penicillin Allergy Reclassification
JAMA Ophthalmology 10.1001/jamaophthalmol.2026.0040March 05, 2026 at 11:00 AM EST
How does penicillin allergy label reclassification and enhanced pharmacy guidance alter rates of intracameral cefuroxime use by cataract surgeons?In this quality improvement study that included 1905 patients with penicillin allergy labels and 3077 cataract surgeries performed by 51 surgeons, mean use of intracameral cefuroxime increased after the policy intervention date compared with before the policy intervention date (by 71% vs 2%, respectively).Implementing structured allergy reclassification and pharmacy collaboration policies may support more appropriate and consistent antibiotic use in patients with penicillin allergy labels undergoing cataract surgery.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.